Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus standard-dose caffeine for apnea of prematurity
PACTR202604505368563Unknown
- Sponsor
- Kyambadde Ronald
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of caffeine in apnea of prematurity (AOP) (2 arms), sponsored by Kyambadde Ronald. Primary endpoint: Frequency and severity of apnea episodes. Status: unknown.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on PACTR202604505368563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202604505368563.